Home › Funds › First Turn Management, LLC › INBX
First Turn Management, LLC position in INBX
INHIBRX BIOSCIENCES INC · Health Care
First Turn Management, LLC reported holding 171,512 shares of INBX (INHIBRX BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$17.2M, representing 2.28% of its reported portfolio and ranking #18 among its reported holdings. First Turn Management, LLC has disclosed INBX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How First Turn Management, LLC's INBX position evolved
First Turn Management, LLC first disclosed a stake in INBX in Q2 2026 at 164,783 shares (US$15.6M). The position peaked in Q3 2026 at 171,512 shares, worth US$17.2M. Across 2 filings, First Turn Management, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 171,512 shares valued at US$17.2M — an increase of 6,729 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 164.78K | $15.61M | New |
| Q3 2026 | 171.51K | $17.16M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About INBX and 13F data
INBX (INHIBRX BIOSCIENCES INC) is a Health Care company. 40 other funds we track also report a position in INBX — the largest reported positions include PERCEPTIVE ADVISORS LLC (US$123.0M), Sanofi (US$115.9M), Schonfeld Strategic Advisors LLC (US$66.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding INBX
- PERCEPTIVE ADVISORS LLC 1.30M sh · $122.96M · Q2 2026
- Sanofi 1.16M sh · $115.89M · Q3 2026
- Schonfeld Strategic Advisors LLC 697.59K sh · $66.10M · Q2 2026
- Sofinnova Investments, Inc. 391.62K sh · $39.19M · Q3 2026
- Parkman Healthcare Partners LLC 360.26K sh · $36.05M · Q3 2026
- PFM Health Sciences, LP 320.33K sh · $32.06M · Q3 2026
- Trails Edge Capital Partners, LP 170.00K sh · $17.01M · Q3 2026
More on First Turn Management, LLC
FAQ
How long has First Turn Management, LLC held INBX?
First Turn Management, LLC has disclosed INBX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is First Turn Management, LLC's current position in INBX?
As of Q3 2026, First Turn Management, LLC holds 171.51K shares of INBX (INHIBRX BIOSCIENCES INC), valued at $17.16M, representing 2.28% of its reported portfolio and ranking #18.
Has First Turn Management, LLC been buying or selling INBX?
In the latest 13F filing (Q3 2026), First Turn Management, LLC increased its position in INBX. The position peaked in Q3 2026 at 171.51K shares.
Which other funds hold INBX?
Other major institutional holders of INBX include PERCEPTIVE ADVISORS LLC, Sanofi, Schonfeld Strategic Advisors LLC, among 40 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.